BE876969A - TAURINE DERIVATIVES WITH ANTILIPEMIC AND CHOLERETIC ACTIVITY, METHOD OF PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT - Google Patents

TAURINE DERIVATIVES WITH ANTILIPEMIC AND CHOLERETIC ACTIVITY, METHOD OF PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT

Info

Publication number
BE876969A
BE876969A BE2/57867A BE2057867A BE876969A BE 876969 A BE876969 A BE 876969A BE 2/57867 A BE2/57867 A BE 2/57867A BE 2057867 A BE2057867 A BE 2057867A BE 876969 A BE876969 A BE 876969A
Authority
BE
Belgium
Prior art keywords
antilipemic
preparing
components
active component
pharmaceutical preparations
Prior art date
Application number
BE2/57867A
Other languages
Dutch (nl)
Original Assignee
Causyth Chim Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Causyth Chim Farm filed Critical Causyth Chim Farm
Publication of BE876969A publication Critical patent/BE876969A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE2/57867A 1978-06-15 1979-06-14 TAURINE DERIVATIVES WITH ANTILIPEMIC AND CHOLERETIC ACTIVITY, METHOD OF PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT BE876969A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24587/78A IT1096662B (en) 1978-06-15 1978-06-15 TAURINIC DERIVATIVES FOR ANTI-LIPEMIC AND CHOLERETIC ACTIVITIES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Publications (1)

Publication Number Publication Date
BE876969A true BE876969A (en) 1979-10-01

Family

ID=11214073

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2/57867A BE876969A (en) 1978-06-15 1979-06-14 TAURINE DERIVATIVES WITH ANTILIPEMIC AND CHOLERETIC ACTIVITY, METHOD OF PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT

Country Status (9)

Country Link
JP (2) JPS5943942B2 (en)
BE (1) BE876969A (en)
DE (1) DE2901046C3 (en)
ES (3) ES476812A1 (en)
FR (2) FR2465717A1 (en)
GB (1) GB2023586B (en)
IT (1) IT1096662B (en)
LU (1) LU81379A1 (en)
NL (1) NL7904644A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1126575B (en) * 1979-12-07 1986-05-21 Causyth Chim Farm COMPOUND WITH ANTI-INFLAMMATORY, ANALGESIC AND ANTI-PIRETIC ACTIVITY, PROCESS FOR ITS PREPARATION, AND RELATED PHARMACEUTICAL COMPOSITIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR920312A (en) * 1944-08-01 1947-04-03 Ward Process for the preparation of nicotic acid derivatives
GB586453A (en) * 1944-08-01 1947-03-19 Ward Blenkinsop & Co Ltd Process for the production of derivatives of nicotinic acid
CH520697A (en) * 1970-03-03 1972-03-31 Sopharma Sa Process for the preparation of a nicotinic acid ester-amide

Also Published As

Publication number Publication date
FR2511365A1 (en) 1983-02-18
DE2901046B2 (en) 1981-07-16
JPS554381A (en) 1980-01-12
FR2465717A1 (en) 1981-03-27
DE2901046C3 (en) 1982-05-06
JPS6133171A (en) 1986-02-17
GB2023586B (en) 1982-08-04
FR2511365B1 (en) 1985-03-15
IT7824587A0 (en) 1978-06-15
ES482484A1 (en) 1980-04-01
NL7904644A (en) 1979-12-18
JPS5943942B2 (en) 1984-10-25
DE2901046A1 (en) 1979-12-20
ES476812A1 (en) 1979-12-16
ES482483A1 (en) 1980-04-16
IT1096662B (en) 1985-08-26
GB2023586A (en) 1980-01-03
LU81379A1 (en) 1979-09-12

Similar Documents

Publication Publication Date Title
NL7803195A (en) HETEROCYCLICAL COMPOUNDS WITH PHARMACEUTICAL ACTIVITY, METHODS FOR THEIR PREPARATION, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7807461A (en) COPOLYESTERS, METHOD OF PREPARATION THEREOF, AND ADHESIVE PREPARATIONS CONTAINING THEM.
NL7810562A (en) UREA DERIVATIVES, METHOD FOR PREPARING THEM AND PHARMACEUTICAL PREPARATIONS.
NL7507268A (en) PROCESS FOR THE PREPARATION OF 1 (ALPHA), 24-DIHYDROXY-CHOLE-CALCIFEROLS, AS WELL AS DERIVATIVES AND PREPARATIONS THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS ACTIVE COMPONENTS.
NL7700379A (en) PROCESS FOR PREPARING ANTHRACYCLINEGLYCOSIDES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7801780A (en) GRANULATES CONTAINING ASCORBIC ACID AND METHOD OF PREPARATION THEREOF.
NL184467B (en) 6-OXO-PROSTAGLANDIN EŸ1 DERIVATIVES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
NL7903650A (en) PURINE DERIVATIVES WITH BRONCHI REMOVAL EFFECT AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS COMPOUND AS AN ACTIVE COMPONENT.
NL950027I2 (en) Alpha-halomethyl-alpha-amino acid derivatives and pharmaceutical preparation containing them.
NL7705141A (en) PROCESS FOR PREPARING PROSTAGLANDIN DERIVATIVES, AND PHARMACEUTICAL PREPARATIONS CONTAINING THIS COMPONENT AS AN ACTIVE COMPONENT.
NL188645B (en) 1-AZAXANTHON-3-CARBONIC ACID COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
NL187397C (en) PHARMACEUTICAL PREPARATIONS, 20,21-DINORO-BURNAMENINE COMPOUNDS THEREFOR AND METHOD FOR THEIR PREPARATION.
NL7610480A (en) PROCESS FOR THE PREPARATION OF HYPOLIPEMIC COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AS AN ACTIVE COMPONENT.
NL7607337A (en) PROCESS FOR THE PREPARATION OF SPIROCYCLOALKYL PROSTANE ACIDS AND ITS DERIVATIVES, AND MEDICINAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7607975A (en) PROCESS FOR PREPARING DIPHENYL SULFIDES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7903769A (en) DI-O-N-ALKYLGLYCEROL DERIVATIVES AND PHARMACEUTICAL PREPARATIONS THEREOF.
IT1109545B (en) DERIVATIVES OF N-FENYL-1,3-OSSAZOLIDIN-2,4-DIONIFUNGICIDES AND PREPARATION PROCEDURE
NL188944C (en) METHOD FOR PREPARING OMEGA-AMINO-KOXYBENZENE DERIVATIVES AND METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS USING THEIR USE AS AN ACTIVE COMPOUND
NL7613041A (en) PROCESS FOR PREPARING PICOLIC ACID DERIVATIVES AND PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
BE876969A (en) TAURINE DERIVATIVES WITH ANTILIPEMIC AND CHOLERETIC ACTIVITY, METHOD OF PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT
NL7802525A (en) SOLID PHARMACEUTICAL PREPARATION AND METHOD OF PREPARATION THEREOF.
NL7803418A (en) 15-DEOXY-16-HYDROXY-16-SUBSTITUATED PROSTANE ACIDS, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7714063A (en) PROCESS FOR THE PREPARATION OF IMIDAZOLINS AND PESTICIDE PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7607494A (en) PROCESS FOR THE PREPARATION OF 2-BENZOPYRAN SUBSTANCES AND MEDICINAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL191366C (en) Esters of acyl derivatives of carnitine, process for their preparation and pharmaceutical preparations containing these derivatives.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: LABORATORIO CHIMICO FARMACEUTICO CAUSYTH S.P.A.

Effective date: 19850614